SML2992
uPSEM792 hydrochloride
≥98% (HPLC)
别名:
1-Methyl-7,8,9,10-tetrahydro-1H-6,10-methanoazepino[4,5-g]quinoxalin-2(6H)-one hydrochloride, PSEM 792 hydrochloride
登录 查看组织和合同定价。
选择尺寸
变更视图
关于此项目
Quality Level
assay
≥98% (HPLC)
form
powder
storage condition
desiccated
color
white to beige
solubility
DMSO: 2 mg/mL, clear
storage temp.
2-8°C
SMILES string
O=C1N(C)C2=CC(C3CNCC4C3)=C4C=C2N=C1.Cl
InChI key
CDHPEJUYEXNGCV-UHFFFAOYSA-N
Biochem/physiol Actions
Ultrapotent PSEM agonist for chimeric ligand-gated ion channel pores with nAChR α7 LBD L181G/Q139L/Y217F mutant (PSAM4) in vitro and in vivo.
uPSEM792 is a selective and ultrapotent pharmacologically selective effector molecule (uPSEM) agonist for chimeric pharmacologically selective actuator modules (PSAMs) with mutant nAChR α7 ligand-binding domain (LBD) PSML181G/Q139L/Y217F (PSAM4) fused to the ion pore domain (IPD) of ligand-gated ion channels (LGICs), including glycine receptor (PSAM4-GlyR EC50 = 2.3 nM) and 5-HT3 (PSAM4-5-HT3 EC50 = 1.6 nM). uPSEM792 exhibits high PSM4 selectivity (>10,000-fold over α7-GlyR, α7-5HT3, 5HT3; >230-fold over α4β2 nAChR) and sub-nanomolar PSAM4-GlyR affinity (Ki = 0.7 nM).
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
Christopher J Magnus et al.
Science (New York, N.Y.), 364(6436) (2019-03-16)
Chemogenetics enables noninvasive chemical control over cell populations in behaving animals. However, existing small-molecule agonists show insufficient potency or selectivity. There is also a need for chemogenetic systems compatible with both research and human therapeutic applications. We developed a new
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| SML2992-25MG | 04065266524451 |
| SML2992-5MG | 04065266524468 |